JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist
  • 3490.0
  • -5.0-0.14%
20min DelayMarket Closed Jul 24 15:00 JST
824.26BMarket Cap25.81P/E (Static)

Rohto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rohto Pharmaceutical Earnings Date

Currency: JPY

Period

Q1 FY2025 Estimates

Aug 7, 2024

Revenue(YoY)

67.66B

+10.61%
EPS(YoY)

39.89

+0.10%
Analyst Rating

Buy

Jul 17, 2024

Rohto Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 73.813B--
Aug 7, 20242025/Q1-- / 67.660B--
May 13, 20242024/Q469.677B / 71.304B--
Feb 9, 20242024/Q373.294B / 73.819B--
Nov 10, 20232024/Q266.698B / 65.582B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 73.813B--
Aug 7, 20242025/Q1-- / 67.660B--
May 13, 20242024/Q469.677B / 71.304B--
Feb 9, 20242024/Q373.294B / 73.819B--
Nov 10, 20232024/Q266.698B / 65.582B--

Unlock Free Earnings Estimates

Rohto Pharmaceutical Earnings Reports

  • Rohto Pharmaceutical: Interim report

    Jul 1 02:37 ET

  • Rohto Pharmaceutical: Confirmation letter

    Jun 27 22:37 ET

  • Rohto Pharmaceutical: Securities Report - 88th period (April 1, 2023 - March 31, 2024)

    Jun 27 22:36 ET

  • Rohto Pharmaceutical: Extraordinary Report

    Jun 3 03:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 17, 2024

    Buy

    • Strong Buy

      44.44%

    • Buy

      55.56%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg